Menu

Sign in

Sign in

Contact us

Homepage > Company > Media > Pharma News > 2018

Pharma News, 2018

Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab

Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab

Zug, Switzerland – March 29, 2018 – Shire plc (LSE.

Israel aims for 100,000 people to volunteer for health database

Israel aims for 100,000 people to volunteer for health database

TEL AVIV (Reuters) - Israel plans to collect data over five years for its digital health project and hopes 100,000 people will volunteer to include their medical records in a database it estim...

Protagonist Therapeutics Discontinues Phase 2b PROPEL Trial of PTG-100 for the Treatment of Ulcerative Colitis following Interim Analysis

Protagonist Therapeutics Discontinues Phase 2b PROPEL Trial of PTG-100 for the Treatment of Ulcerative Colitis following Interim Analysis

Phase III IMpower150 study showed Roche’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus carboplatin and paclitaxel helped people with advanced lung cancer live longer compared to Avastin plus carboplatin and paclitaxel

Phase III IMpower150 study showed Roche’s TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus carboplatin and paclitaxel helped people with advanced lung cancer live longer compared to Avastin plus carboplatin and paclitaxel

Drug compound shows promise against rheumatoid arthritis

Drug compound shows promise against rheumatoid arthritis

Scientists have designed a new drug compound that dials down inflammation, suggesting possible future uses against autoimmune disorders such as rheumatoid arthritis.

Drugmaker Shire soars as Japan's Takeda considers bid

Drugmaker Shire soars as Japan's Takeda considers bid

LONDON/TOKYO (Reuters) - Japan’s largest drugmaker Takeda Pharmaceutical (4502.

New drug significantly reduces smoking habit in heart attack patients

New drug significantly reduces smoking habit in heart attack patients

Patients who smoke after an acute coronary syndrome, including a heart attack (myocardial infarction) or unstable angina (reduced blood flow to the heart) are at increased risk of anot...

Alzheimer's solution that requires 'no prescription or doctor': Painkiller ibuprofen could 'eliminate' the disease, reveal scientists

Alzheimer's solution that requires 'no prescription or doctor': Painkiller ibuprofen could 'eliminate' the disease, reveal scientists

Ibuprofen could prevent Alzheimer's disease, scientists claim.

Newly-discovered human organ may help explain how cancer spreads

Newly-discovered human organ may help explain how cancer spreads

A newly discovered network of fluid-filled channels in the human body may be a previously-unknown organ, and it seems to help transport cancer cells around the body.

Scientists Use Synthesized Antibiotic to Treat Bacterial Infection in Mice for the First Time

Scientists Use Synthesized Antibiotic to Treat Bacterial Infection in Mice for the First Time

In 2015, scientists discovered a new antibiotic called teixobactin.

Biohaven shares drop 23% after migraine drug trial results

Biohaven shares drop 23% after migraine drug trial results

Biohaven Pharmaceutical Holding Co.

300 million hepatitis B sufferers but only one in 20 treated: study

300 million hepatitis B sufferers but only one in 20 treated: study

Some 300 million people worldwide are living with the deadly hepatitis B virus (HBV), but only one in 20 received adequate treatment, researchers reported Tuesday.

51 52 53 545556 57 58 59

0 items in Cart

Cart Subtotal:

You will be able to Pay Online or Request a Quote